Why the study?
Does SCA40 activate BKCa channels in bovine tracheal smooth muscle cells compared to NS 004 and NS 1619?
Does SCA40 activate BKCa channels in bovine tracheal smooth muscle cells compared to NS 004 and NS 1619?
SCA40 does not directly activate BKCa channels in bovine tracheal smooth muscle cells, suggesting its relaxant action is mediated by a different mechanism.
SCA40 lacks BKCa activity in bovine tracheal myocytes; leaves open alternative mechanisms for its relaxant effects in animal models.
The effects of imidazopyrazine derivative, SCA40, on the activity of single large conductance, Ca(2+)-activated K+ (BKCa) channels in inside-out and outside-out patches from bovine tracheal smooth muscle (BTSM) cells in culture have been compared with those of two established BKCa channel openers, NS 004 and NS 1619. 2. The presence of BKCa channels on inside-out patches of BTSM membranes was confirmed by the single channel conductance (240 pS), selectivity for K+, dependence of channel activity on [Ca2+]i, and sensitivity to the selective BKCa channel blocker, iberiotoxin. 3. NS 004 and ND 1619 (3-30 microM) induced concentration-related increases in open state probability of BKCa channels when applied to either inside-out or outside-out BTSM patches, thus confirming that these compounds are activators of the BKCa channel in this preparation. 4. SCA40 (0.1-10 microM) had no effect on the activity of BKCa channels when applied to either inside-out or outside-out patches which subsequently responded to the application of NS 004 (10-20 microM). 5. It is concluded that SCA40 does not have a direct effect on BKCa channel activity in BTSM patches and that the previously reported relaxant action of SCA40 on tracheal smooth muscle is unlikely to be mediated by this mechanism.
No takes yet. Share an insight, caveat, or question.
Macmillan et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: